-
Product Name
Namilumab (Synonyms: ANTI-HGM-CSF IGG1)
- Documents
-
Description
Anti-CSF2 / GM-CSF Antibody (Namilumab)
-
Tested applications
ELISA
-
Species reactivity
Human CSF2 / GM-CSF
-
Alternative names
ANTI-HGM-CSF IGG1 antibody
-
Isotype
IgG1
-
Preparation
Recombinant expression and purified from CHO cells.
-
Clonality
Monoclonal
-
Formulation
0.1 M Pro-Ac, 20 mM Arg, pH 5.0
-
Storage instructions
-80°C for 2 years under sterile conditions; -20°C for 1 year under sterile conditions; Avoid repeated freeze-thaw cycles.
-
Validations
SDS-PAGE
Anti-CSF2 / GM-CSF Antibody (namilumab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 90%.
SEC-HPLC
The purity of Anti-CSF2 / GM-CSF Antibody (namilumab) is 90.29%, determined by SEC-HPLC.
Bioactivity: ELISA
Immobilized human GM CSF Nhis at 2 ug/mL can bind Anti-CSF2 / GM-CSF Antibody (namilumab), EC50=0.008074 ug/mL.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"